Cerebrospinal fluid and dural accumulation of α-synuclein impairs CNS clearance in Parkinson's disease.

Accumulation of α-synuclein in CSF and dura mater is linked to CNS clearance deficits in Parkinson's disease patients.

• Why it matters: Understanding how α-synuclein contributes to neurodegeneration is crucial, as its accumulation in CSF and dura mater may impair CNS waste removal, impacting disease progression.
• What they did: The study examined α-synuclein levels in CSF and dura mater of PD patients and used mouse models to investigate its effects on CNS clearance, immune responses, and lymphatic cell function.
• The result: Findings show α-synuclein deposits elevate CSF TNF and impair lymphatic endothelial cells, suggesting meningeal immune alterations may contribute to CNS clearance deficits in PD.